Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 62

1.

Summary of the Vaccines and Related Biological Products Advisory Committee meeting held to consider evaluation of vaccine candidates for the prevention of respiratory syncytial virus disease in RSV-naïve infants.

Browne SK, Beeler JA, Roberts JN.

Vaccine. 2019 Nov 6. pii: S0264-410X(19)31428-8. doi: 10.1016/j.vaccine.2019.10.048. [Epub ahead of print]

PMID:
31706809
2.

Factors Associated With Discussions of Human Immunodeficiency Virus Pre-Exposure Prophylaxis in Men Who Have Sex With Men.

Halton BR, Roberts JNT, Denton GD.

Ochsner J. 2019 Fall;19(3):188-193. doi: 10.31486/toj.19.0004.

3.

Breeding bulls as a potential source of bovine leukemia virus transmission in beef herds.

Benitez OJ, Roberts JN, Norby B, Bartlett PC, Takeshima SN, Watanuki S, Aida Y, Grooms DL.

J Am Vet Med Assoc. 2019 Jun 1;254(11):1335-1340. doi: 10.2460/javma.254.11.1335.

PMID:
31067187
4.

Impact of uterine macrophage phenotype on placental retention in dairy cows.

Nelli RK, De Koster J, Roberts JN, de Souza J, Lock AL, Raphael W, Agnew D, Contreras GA.

Theriogenology. 2019 Mar 15;127:145-152. doi: 10.1016/j.theriogenology.2019.01.011. Epub 2019 Jan 19.

PMID:
30695743
5.

Lack of Bovine leukemia virus transmission during natural breeding of cattle.

Benitez OJ, Roberts JN, Norby B, Bartlett PC, Maeroff JE, Grooms DL.

Theriogenology. 2019 Mar 1;126:187-190. doi: 10.1016/j.theriogenology.2018.12.005. Epub 2018 Dec 3.

PMID:
30557791
6.

Assessing the Financial Value of Patient Engagement: A Quantitative Approach from CTTI's Patient Groups and Clinical Trials Project.

Levitan B, Getz K, Eisenstein EL, Goldberg M, Harker M, Hesterlee S, Patrick-Lake B, Roberts JN, DiMasi J.

Ther Innov Regul Sci. 2018 Mar;52(2):220-229. doi: 10.1177/2168479017716715. Epub 2017 Jul 17.

7.

The Rules of Engagement: CTTI Recommendations for Successful Collaborations Between Sponsors and Patient Groups Around Clinical Trials.

Bloom D, Beetsch J, Harker M, Hesterlee S, Moreira P, Patrick-Lake B, Selig W, Sherman J, Smith SK, Valentine JE, Roberts JN.

Ther Innov Regul Sci. 2018 Mar;52(2):206-213. doi: 10.1177/2168479017720247. Epub 2017 Jul 27.

8.

Facilitators and barriers to the successful implementation of pediatric antibacterial drug trials: Findings from CTTI's survey of investigators.

Corneli A, Wheeler C, Bradley J, Gamel B, Nambiar S, Noel GJ, Lin L, Roberts JN, Benjamin DK Jr.

Contemp Clin Trials Commun. 2018 Jan 31;9:115-120. doi: 10.1016/j.conctc.2018.01.003. eCollection 2018 Mar.

9.

Clinical trials recruitment planning: A proposed framework from the Clinical Trials Transformation Initiative.

Huang GD, Bull J, Johnston McKee K, Mahon E, Harper B, Roberts JN; CTTI Recruitment Project Team.

Contemp Clin Trials. 2018 Mar;66:74-79. doi: 10.1016/j.cct.2018.01.003. Epub 2018 Jan 9.

10.

Time-dependent changes in pregnancy-associated glycoproteins and progesterone in commercial crossbred sheep.

Roberts JN, May KJ, Veiga-Lopez A.

Theriogenology. 2017 Feb;89:271-279. doi: 10.1016/j.theriogenology.2016.10.029. Epub 2016 Nov 9.

PMID:
28043363
11.

Challenges and opportunities in RSV vaccine development: Meeting report from FDA/NIH workshop.

Roberts JN, Graham BS, Karron RA, Munoz FM, Falsey AR, Anderson LJ, Marshall V, Kim S, Beeler JA.

Vaccine. 2016 Sep 22;34(41):4843-4849. doi: 10.1016/j.vaccine.2016.07.057. Epub 2016 Aug 25.

PMID:
27566900
12.

Dynamic Surfaces for the Study of Mesenchymal Stem Cell Growth through Adhesion Regulation.

Roberts JN, Sahoo JK, McNamara LE, Burgess KV, Yang J, Alakpa EV, Anderson HJ, Hay J, Turner LA, Yarwood SJ, Zelzer M, Oreffo RO, Ulijn RV, Dalby MJ.

ACS Nano. 2016 Jul 26;10(7):6667-79. doi: 10.1021/acsnano.6b01765. Epub 2016 Jun 27.

13.

Patient Engagement Practices in Clinical Research among Patient Groups, Industry, and Academia in the United States: A Survey.

Smith SK, Selig W, Harker M, Roberts JN, Hesterlee S, Leventhal D, Klein R, Patrick-Lake B, Abernethy AP.

PLoS One. 2015 Oct 14;10(10):e0140232. doi: 10.1371/journal.pone.0140232. eCollection 2015.

14.

Biobanking in the Twenty-First Century: Driving Population Metrics into Biobanking Quality.

Roberts JN, Karvonen C, Graham K, Weinfeld M, Joy AA, Koebel M, Morris D, Robson PJ, Johnston RN, Brockton NT.

Adv Exp Med Biol. 2015;864:95-114. doi: 10.1007/978-3-319-20579-3_8. Review.

PMID:
26420616
15.

Human papillomavirus capsids preferentially bind and infect tumor cells.

Kines RC, Cerio RJ, Roberts JN, Thompson CD, de Los Pinos E, Lowy DR, Schiller JT.

Int J Cancer. 2016 Feb 15;138(4):901-11. doi: 10.1002/ijc.29823. Epub 2015 Oct 27.

16.

Theriogenology Question of the Month. Enlarged ovary due to granulosa theca cell tumor.

Roberts JN, Carleton CL, Conley AJ, Agnew DW.

J Am Vet Med Assoc. 2015 Jul 15;247(2):153-5. doi: 10.2460/javma.247.2.153. No abstract available.

PMID:
26133212
17.

Application of an ELISA Milk Pregnancy Test in Beef Cows.

Roberts JN, Byrem TM, Grooms DL.

Reprod Domest Anim. 2015 Aug;50(4):651-8. doi: 10.1111/rda.12546. Epub 2015 Jun 8.

PMID:
26058919
18.

Regulatory considerations in the clinical development of vaccines indicated for use during pregnancy.

Roberts JN, Gruber MF.

Vaccine. 2015 Feb 18;33(8):966-72. doi: 10.1016/j.vaccine.2014.12.068. Epub 2015 Jan 6. Review.

PMID:
25573034
19.

Dynamic acoustic field activated cell separation (DAFACS).

Skotis GD, Cumming DR, Roberts JN, Riehle MO, Bernassau AL.

Lab Chip. 2015 Feb 7;15(3):802-10. doi: 10.1039/c4lc01153h.

PMID:
25474444
20.

Osteogenic lineage restriction by osteoprogenitors cultured on nanometric grooved surfaces: the role of focal adhesion maturation.

Cassidy JW, Roberts JN, Smith CA, Robertson M, White K, Biggs MJ, Oreffo RO, Dalby MJ.

Acta Biomater. 2014 Feb;10(2):651-60. doi: 10.1016/j.actbio.2013.11.008. Epub 2013 Nov 16.

21.

The Ethnic/Racial Variations of Intracerebral Hemorrhage (ERICH) study protocol.

Woo D, Rosand J, Kidwell C, McCauley JL, Osborne J, Brown MW, West SE, Rademacher EW, Waddy S, Roberts JN, Koch S, Gonzales NR, Sung G, Kittner SJ, Birnbaum L, Frankel M, Testai FD, Hall CE, Elkind MS, Flaherty M, Coull B, Chong JY, Warwick T, Malkoff M, James ML, Ali LK, Worrall BB, Jones F, Watson T, Leonard A, Martinez R, Sacco RI, Langefeld CD.

Stroke. 2013 Oct;44(10):e120-5. doi: 10.1161/STROKEAHA.113.002332. Epub 2013 Sep 10.

22.

Interventions to increase enrollment in a large multicenter phase 3 trial of carotid stenting vs. endarterectomy.

Longbottom ME, Roberts JN, Tom M, Hughes SE, Howard VJ, Sheffet AJ, Meschia JF, Brott TG; CREST Investigators.

Int J Stroke. 2012 Aug;7(6):447-53. doi: 10.1111/j.1747-4949.2012.00833.x. Epub 2012 May 28.

23.

Topography as a tool to facilitate endocytosis.

Dalby MJ, Macintyre A, Roberts JN, Yang J, Lee LC, Tsimbouri PM, McNamara LE.

Nanomedicine (Lond). 2012 Jan;7(1):21. No abstract available.

PMID:
22299171
24.

Nanoscale titanium surface treatments for marrow progenitor culture.

Dalby MJ, Macintyre A, Roberts JN, Yang J, Lee LC, Tsimbouri PM, McNamara LE.

Nanomedicine (Lond). 2012 Jan;7(1):20-1. No abstract available.

PMID:
22299170
25.

Influence of local ligand density on formation of focal adhesions on nano- and micro-nanostructured surfaces.

Dalby MJ, Macintyre A, Roberts JN, Yang J, Lee LC, Tsimbouri PM, McNamara LE.

Nanomedicine (Lond). 2012 Jan;7(1):20. No abstract available.

PMID:
22299169
26.

Nanoporous titanium substrates for osteogenesis.

Dalby MJ, Macintyre A, Roberts JN, Yang J, Lee LC, Tsimbouri PM, McNamara LE.

Nanomedicine (Lond). 2012 Jan;7(1):19. No abstract available.

PMID:
22299168
27.

Nanosubstrates to illustrate differential adhesion mechanisms to fibronectin and vitronectin.

Dalby MJ, Macintyre A, Roberts JN, Yang J, Lee LC, Tsimbouri PM, McNamara LE.

Nanomedicine (Lond). 2012 Jan;7(1):18. No abstract available.

PMID:
22299167
28.

3D patterned agarose hydrogels for investigation of precursor cells in differentiation and chemoattraction.

Dalby MJ, Macintyre A, Roberts JN, Yang J, Lee LC, Tsimbouri PM, McNamara LE.

Nanomedicine (Lond). 2012 Jan;7(1):17. doi: 10.2217/nnm.11.172. No abstract available.

PMID:
22191776
29.

Targeting the vaginal mucosa with human papillomavirus pseudovirion vaccines delivering simian immunodeficiency virus DNA.

Gordon SN, Kines RC, Kutsyna G, Ma ZM, Hryniewicz A, Roberts JN, Fenizia C, Hidajat R, Brocca-Cofano E, Cuburu N, Buck CB, Bernardo ML, Robert-Guroff M, Miller CJ, Graham BS, Lowy DR, Schiller JT, Franchini G.

J Immunol. 2012 Jan 15;188(2):714-23. doi: 10.4049/jimmunol.1101404. Epub 2011 Dec 14.

30.

Characterization of dye-decolorizing peroxidases from Rhodococcus jostii RHA1.

Roberts JN, Singh R, Grigg JC, Murphy ME, Bugg TD, Eltis LD.

Biochemistry. 2011 Jun 14;50(23):5108-19. doi: 10.1021/bi200427h. Epub 2011 May 19.

PMID:
21534572
31.

Identification of DypB from Rhodococcus jostii RHA1 as a lignin peroxidase.

Ahmad M, Roberts JN, Hardiman EM, Singh R, Eltis LD, Bugg TD.

Biochemistry. 2011 Jun 14;50(23):5096-107. doi: 10.1021/bi101892z. Epub 2011 May 19.

PMID:
21534568
32.

Double oxidation of the cyclic nonaketide dihydromonacolin L to monacolin J by a single cytochrome P450 monooxygenase, LovA.

Barriuso J, Nguyen DT, Li JW, Roberts JN, MacNevin G, Chaytor JL, Marcus SL, Vederas JC, Ro DK.

J Am Chem Soc. 2011 Jun 1;133(21):8078-81. doi: 10.1021/ja201138v. Epub 2011 Apr 15.

PMID:
21495633
33.

Effect of Pap smear collection and carrageenan on cervicovaginal human papillomavirus-16 infection in a rhesus macaque model.

Roberts JN, Kines RC, Katki HA, Lowy DR, Schiller JT.

J Natl Cancer Inst. 2011 May 4;103(9):737-43. doi: 10.1093/jnci/djr061. Epub 2011 Apr 11.

34.

In vivo longitudinal imaging of experimental human papillomavirus infection in mice with a multicolor fluorescence mini-endoscopy system.

Mitsunaga M, Kosaka N, Kines RC, Roberts JN, Lowy DR, Schiller JT, Ishihara Y, Hasegawa A, Choyke PL, Kobayashi H.

Cancer Prev Res (Phila). 2011 May;4(5):767-73. doi: 10.1158/1940-6207.CAPR-10-0334. Epub 2011 Mar 23.

35.

Adventures in Rhodococcus - from steroids to explosives.

Yam KC, Okamoto S, Roberts JN, Eltis LD.

Can J Microbiol. 2011 Mar;57(3):155-68. doi: 10.1139/W10-115. Review.

PMID:
21358756
36.

Mucosal delivery of human papillomavirus pseudovirus-encapsidated plasmids improves the potency of DNA vaccination.

Graham BS, Kines RC, Corbett KS, Nicewonger J, Johnson TR, Chen M, LaVigne D, Roberts JN, Cuburu N, Schiller JT, Buck CB.

Mucosal Immunol. 2010 Sep;3(5):475-86. doi: 10.1038/mi.2010.31. Epub 2010 Jun 16.

37.

Improvement in duration of erection following phosphodiesterase type 5 inhibitor therapy with vardenafil in men with erectile dysfunction: the ENDURANCE study.

Rosenberg MT, Adams PL, McBride TA, Roberts JN, McCallum SW.

Int J Clin Pract. 2009 Jan;63(1):27-34. doi: 10.1111/j.1742-1241.2008.01947.x.

38.

Role of heparan sulfate in attachment to and infection of the murine female genital tract by human papillomavirus.

Johnson KM, Kines RC, Roberts JN, Lowy DR, Schiller JT, Day PM.

J Virol. 2009 Mar;83(5):2067-74. doi: 10.1128/JVI.02190-08. Epub 2008 Dec 10.

39.

Inhibition of yeast telomerase action by the telomeric ssDNA-binding protein, Cdc13p.

Zappulla DC, Roberts JN, Goodrich KJ, Cech TR, Wuttke DS.

Nucleic Acids Res. 2009 Feb;37(2):354-67. doi: 10.1093/nar/gkn830. Epub 2008 Nov 29.

40.

Protection against heterologous human papillomavirus challenge by a synthetic lipopeptide vaccine containing a broadly cross-neutralizing epitope of L2.

Alphs HH, Gambhira R, Karanam B, Roberts JN, Jagu S, Schiller JT, Zeng W, Jackson DC, Roden RB.

Proc Natl Acad Sci U S A. 2008 Apr 15;105(15):5850-5. doi: 10.1073/pnas.0800868105. Epub 2008 Apr 14.

41.

High concentration formulations of recombinant human interleukin-1 receptor antagonist: I. Physical characterization.

Alford JR, Kwok SC, Roberts JN, Wuttke DS, Kendrick BS, Carpenter JF, Randolph TW.

J Pharm Sci. 2008 Aug;97(8):3035-50.

42.

A protective and broadly cross-neutralizing epitope of human papillomavirus L2.

Gambhira R, Karanam B, Jagu S, Roberts JN, Buck CB, Bossis I, Alphs H, Culp T, Christensen ND, Roden RB.

J Virol. 2007 Dec;81(24):13927-31. Epub 2007 Oct 10.

43.

Genital transmission of HPV in a mouse model is potentiated by nonoxynol-9 and inhibited by carrageenan.

Roberts JN, Buck CB, Thompson CD, Kines R, Bernardo M, Choyke PL, Lowy DR, Schiller JT.

Nat Med. 2007 Jul;13(7):857-61. Epub 2007 Jul 1.

PMID:
17603495
44.

A randomized, placebo-controlled trial assessing the effects of rosiglitazone on echocardiographic function and cardiac status in type 2 diabetic patients with New York Heart Association Functional Class I or II Heart Failure.

Dargie HJ, Hildebrandt PR, Riegger GA, McMurray JJ, McMorn SO, Roberts JN, Zambanini A, Wilding JP.

J Am Coll Cardiol. 2007 Apr 24;49(16):1696-704. Epub 2007 Apr 6.

45.

Carrageenan is a potent inhibitor of papillomavirus infection.

Buck CB, Thompson CD, Roberts JN, Müller M, Lowy DR, Schiller JT.

PLoS Pathog. 2006 Jul;2(7):e69.

46.

The effect of dermatologic precautions on the incidence of rash with addition of lamotrigine in the treatment of bipolar I disorder: a randomized trial.

Ketter TA, Greist JH, Graham JA, Roberts JN, Thompson TR, Nanry KP.

J Clin Psychiatry. 2006 Mar;67(3):400-6.

PMID:
16649826
47.

Active Stat3 is required for survival of human squamous cell carcinoma cells in serum-free conditions.

Yin W, Cheepala S, Roberts JN, Syson-Chan K, DiGiovanni J, Clifford JL.

Mol Cancer. 2006 Apr 7;5:15.

48.

Identification and characterization of the human retinoid X receptor alpha gene promoter.

Li G, Yin W, Chamberlain R, Hewett-Emmett D, Roberts JN, Yang X, Lippman SM, Clifford JL.

Gene. 2006 May 10;372:118-27. Epub 2006 Mar 6.

PMID:
16517099
49.

Abnormal mitochondrial function and muscle wasting, but normal contractile efficiency, in haemodialysed patients studied non-invasively in vivo.

Kemp GJ, Crowe AV, Anijeet HK, Gong QY, Bimson WE, Frostick SP, Bone JM, Bell GM, Roberts JN.

Nephrol Dial Transplant. 2004 Jun;19(6):1520-7. Epub 2004 Mar 5.

PMID:
15004250
50.

Patients' preference of valacyclovir once-daily suppressive therapy versus twice-daily episodic therapy for recurrent genital herpes: a randomized study.

Romanowski B, Marina RB, Roberts JN; Valtrex HS230017 Study Group.

Sex Transm Dis. 2003 Mar;30(3):226-31.

PMID:
12616141

Supplemental Content

Loading ...
Support Center